Barbuti, Margherita
Carignani, Giulia
Weiss, Francesco
Calderone, Alba
Fierabracci, Paola
Salvetti, Guido
Menculini, Giulia
Tortorella, Alfonso
Santini, Ferruccio
Perugi, Giulio
Funding for this research was provided by:
Università di Pisa
Article History
Received: 31 March 2023
Accepted: 14 May 2023
First Online: 2 June 2023
Declarations
:
: Giulia Menculini received travel grants from Angelini and Lundbeck. Alfonso Tortorella received research support/travel grants, and served as speaker for, Angelini and Lundbeck. Ferruccio Santini has acted as a consultant, has received grant/research support and/or is on the speaker/advisory board for NovoNordisk, Bruno Farmaceutici, Aegerion-Amrit, Bio Italia srl. Giulio Perugi acted as consultant to Lundbeck, Angelini, and FB-Health. He received a scholarship/research support from Lundbeck and Angelini. He is a member of the speaker/advisory board of Sanofi-Aventis, Lundbeck, FB-Health, and Angelini. Other authors have no conflict of interest to declare.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Pisa (Protocol n. 23933; 29/03/2019).
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.